ZFAS1 and head and neck squamous cell carcinoma: HNSCC patients were divided into three main localization groups: oral cavity (n = 314), pharynx (n = 90) and larynx (n = 116), according to the National Institute of Health (NIH) classification, and expression levels of ZFAS1 were analyzed.